GlaxoSmithKline
Top Pharmaceutical Promoter to Leading Managed Care Decision Makers, Cognet~X,
Inc. Reports
FEASTERVILLE---(February
14, 2002)---In its first full year post-merger, GlaxoSmithKline made its
presence known to influential managed care executives. According to Cognet~X,
Inc. data, GlaxoSmithKline generated the most promotional contacts to key
managed care pharmacy directors during 2001.
Data from Cognet~X’s PAR-Rx (Promotional Assessment
Research) Report™ indicate that GlaxoSmithKline surpassed the promotional
level of its nearest competitor by 18% for the full year. The PAR-Rx Report
tracks promotion to the most influential pharmacy directors in the managed
care marketplace.
During the first three of 2001,
GlaxoSmithKline generated more contacts to PAR-Rx panelists than did any other
corporation as the new company introduced itself and its combined product
portfolio to key managed care customers. Among the top-promoted GSK brands:
the asthma medication Advair Diskus, the oral antidiabetic agent Avandia and
the antidepressant Paxil.
In the fourth quarter, Novartis
Pharmaceuticals Corp. placed first, and GlaxoSmithKline was second.
Johnson & Johnson placed second
for the full-year totals, as its fourth-quarter promotion climbed 25% due to
increased contacts for proton pump inhibitor Aciphex (which Janssen
Pharmaceutica co-markets with Eisai Inc.) and Ortho-McNeil Pharmaceutical’s
quinolone antibiotic Levaquin.
According to PAR-Rx Report data,
Johnson & Johnson was followed closely by Merck & Co. Inc., Novartis
Pharmaceuticals Corp., Pfizer and American Home Products Co. Fourth-quarter
promotion by Novartis and American Home Products rose above third-quarter
levels rose 32% and 22%, respectively, above third-quarter levels.
Abbott Laboratories placed seventh
in full-year promotional activity. AstraZeneca PLC and Aventis Pharma AG tied
for eighth-place overall, as Aventis’ fourth-quarter promotion rose nearly
40%. Bristol-Myers Squibb Co. and Pharmacia Corp. rounded out the top 10
corporations, Cognet~X data show.
About the PAR-Rx Report
Cognet~X’s PAR-Rx Report is a
year-round service that provides the pharmaceutical industry with real-time,
Internet-based competitive intelligence on pharmaceutical company promotion to
influential managed care pharmacy directors.
The Report offers Cognet~X clients
the ability to evaluate and analyze variable differences that are critically
important to their decision-making process. The Report collects comprehensive
data that can be segmented and analyzed to provide clients with “21st-Century
solutions to their 21st-Century challenges.”
About Cognet~X
Cognet~X
offers the pharmaceutical
industry market research, consulting and software development that help
companies build and refine their relationships with numerous customer bases,
including the managed care community. Based in Bucks County, Pennsylvania, Cognet~X
is privately held and employee owned.
For more information on the
PAR-Rx Report or other valuable Cognet~X products, please contact Robert E.
Houghton (extension 101) at (215) 396-8300 or via e-mail at robh@cognetx.com.
